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QUANTIFICATION OF CARTILAGINOUS CALLUS BY CONTRAST ENHANCED
MICRO COMPUTED TOMOGRAPHY IMAGING FOR FRACTURE HEALING
EVALUATION
S. K. H. Chow, U. Y. Chow, K. S. Leung, W. H. Cheung
Department of Orthopaedics and Traumatology, The Chinese University of
Hong Kong, Hong Kong
Objective: Formation of soft cartilaginous callus to stabilize the fracture
site is an important stage in the healing process. Computed Tomography
(CT), which is a non-destructive approach, can be a useful tool in the studies
of fracture healing. However, the low radio-opacity of cartilage hampered
the use of CT as it is nearly invisible on radiographs or CT scans in the early
stages of healing.
Methods: This study used a combination of a commercially available anionic
contrast agent known as Hexabrix and micro-computed tomography (mCT)
to visualize the soft cartilaginous callus around the fracture site in rats. A
transverse, unilateral and closed fracture was made on the right femur of
each rat. Fracture calluses were scanned before and after the incubation
in different concentrations of Hexabrix from 10% to 40%, resulting in
non-uniform distribution of anionic contrast agent depending on the electro-
chemical interaction between the contrast agent and negatively-charged
sulfated glycosaminoglycans (sGAGs) in the cartilage. The CT images were
then segmented, reconstructed and evaluated for both morphological and
compositional analyses. The volumes identified with contrast-enhanced
computed tomography (CECT) were compared with the area obtained from
the gold standard histological assessment.
Results: Dilution of anionic contrast agent to 20% was found to be the
optimal concentration that allowed both qualitative identification and quan-
titative analyses of the cartilages. The callus volume measured using 20%
contrast agent with CECT was also strongly predictive of the corresponding
histological measurements.
Conclusion: These findings show that non-invasive CECT allows visualization
of soft cartilaginous callus and quantification of the callus composition,
enabling a more comprehensive examination of fracture healing on animal
models thanks to the non-destructive feature that allows future mechanical
testing.
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RESTORATION OF ESTROGEN RECEPTOR EXPRESSION IN OSTEOPOROTIC
FRACTURE BY LOW MAGNITUDE HIGH FREQUENCY VIBRATION THERAPY
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Hong Kong, Hong Kong
Introduction: Osteoporotic fracture healing was shown to respond differ-
ently to mechanical stimulation from normal fracture, possibly due to
delayed estrogen receptors (ER) expression for mechanical signal transduc-
tion. We hypothesized that Low-Magnitude High-Frequency Vibration
(LMHFV) could restore ER-a and ER-b gene expression, thus accelerate oste-
oporotic fracture healing.
Methods: Seventy-two osteoporotic SD rat fracture model was used to inves-
tigate the effect of LMHFV on the callus morphometry, estrogen receptor
expression quantified by real-time PCR, and ER-immunohistochemistry
(IHC) and micro-CT. Fractured rats were assigned to SHAM, OVX and OVX-
VT group, assessed at 2, 4, 8 weeks post-fracture (gene: nZ5/group/time-
point, IHC: nZ3/group/time-point).
Results: SHAM and OVX-VT showed higher callus size than OVX group from 2
to 4 weeks (all p<0.05). Both ER-a (p<0.001) and ER-b (pZ0.003) gene
expression was higher in the CTRL and OVX-VT groups at 2 weeks. BMP-2
expression was higher at week-2 (pZ0.007) and week-4 (pZ0.001) in
SHAM and OVX-VT groups. IHC showed generally stronger signal in the
SHAM and OVX-VT groups than the OVX group at week 2. Micro-CT showed
higher low-density callus volume in the OVX-VT group.
Conclusion: Osteoporotic fracture healing was shown to be accelerated by
LMHFV by callus morphometry. ER and BMP-2 expression levels were shown
to be comparable between SHAM in OVX-VT at early stage of fracture healing
over the OVX group. IHC also demonstrated similar observation. We conclude
that expression in ERs in osteoporotic fracture healing could be restored by
LMHFV, thus leading to differential healing responses to mechanical
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A NOVEL BONE TARGETING DELIVERY SYSTEM CARRYING BONE-FORMING
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Objective: The treatment strategy of steroid-associated osteonecrosis
(SAON) is to promote bone formation and inhibit bone resorption in
early stages. We found a semisynthesized small phytomolecule namely
icaritin that presented the properties of osteogenesis and anti-bone
resorption. The current study developed a novel bone-targeting inject-
able Asp8-liposome-icaritin (ASP-LP-ICT). As coupling of osteoblasts and
osteoclasts play key roles in bone turnover, this study aims to report
on the histological and cytological evaluation of ASP-LP-ICT developed
for SAON prevention.
Methods: Based on our established technology, ASP-LP-ICT was first synthe-
sized by thin film evaporation method. SAON model was established in
twenty-four male Sprague Dawley rats (32020g). The procedure was briefly
performed by once intravenous injections by tail vein of 40 mg/kg lipopolysac-
charide (LPS), and then three times intramuscular injections of 40mg/kgmeth-
ylprednisolone (MPS) at a time interval of 24 hrs. At 2 weeks post the last
injection, the SAON rats were divided into four groups: SAON control (ONC)
and treatment groups (ASP-LP-ICT, LP-ICT and ASP-LP) that were subjected
to once injection per week for two weeks according to ICT dosage of 16 mg/
kg with different formulations. Other six normal rats served as normal control
(NC). As the termination, coronal paraffin sections of femoral head were pre-
pared for tartrate-resistant acid phosphatase (TRAP) staining. The region of
2.76 mm1.38 mm in trabecular bone below growth plate was defined for
quantification. The parameters measured were bone surface (BS), osteoblasts
surface (Ob.S), osteoclasts number (N.Oc) and eroded surface (ES).
Results: The staining results presented the difference between ONC and
treatment groups. Based on the respective comparison of Ob.S/BS, ES/BS,
N.Oc/BS and N.Oc/ES, compared to the values in ONC group (19.792%,
23.130%, 5.216 and 22.577), there were significant differences in ASP-LP-
ICT group (33.787%, 10.592%, 3.283 and 31.440) (p<0.05, nZ6) that indi-
cated the optional effects of osteoblasts enhancement and osteoclasts
reduction. However, for LP-ICT and ASP-LP groups, as compared to ONC
group, except there was significant reduction in N.Oc (p<0.05, nZ6), other
results showed no significant difference (p>0.01, nZ6).
Conclusion: In SAON prevention, the innovative injectable Asp8-lipo-
some-icaritin system was effective not only in bone-forming enhance-
ment, but also in bone resorption inhibition that mainly through
specific suppression of osteoclasts erosion effect, but not simple reduc-
tion of osteoclasts number or lifespan in contrast to the delivery system
without Asp8 or icaritin.
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